Richard J-L, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M, Lavigne J-P
Department of Nutrition and Diabetes, Medical Center, 30240 Le Grau-du-Roi, France.
Diabetes Metab. 2008 Sep;34(4 Pt 1):363-9. doi: 10.1016/j.diabet.2008.02.005. Epub 2008 Jul 15.
To determine the risk factors for acquiring multidrug-resistant organisms (MDRO) and their impact on outcome in infected diabetic foot ulcers.
Patients hospitalized in our diabetic foot unit for an episode of infected foot ulcer were prospectively included. Diagnosis of infection was based on clinical findings using the International Working Group on the Diabetic Foot-Infectious Diseases Society of America (IWGDF-ISDA) system, and wound specimens were obtained for bacterial cultures. Each patient was followed-up for 1 year. Univariate analysis was performed to compare infected ulcers according to the presence or absence of MDRO; logistic regression was used to identify explanatory variables for MDRO presence. Factors related to healing time were evaluated by univariate and multivariate survival analyses.
MDRO were isolated in 45 (23.9%) of the 188 patients studied. Deep and recurrent ulcer, previous hospitalization, HbA(1c) level, nephropathy and retinopathy were significantly associated with MDRO-infected ulceration. By multivariate analysis, previous hospitalization (OR=99.6, 95% CI=[19.9-499.0]) and proliferative retinopathy (OR=7.4, 95% CI=[1.6-33.7]) significantly increased the risk of MDRO infection. Superficial ulcers were associated with a significant decrease in healing time, whereas neuroischaemic ulcer, proliferative retinopathy and high HbA(1c) level were associated with an increased healing time. In the multivariate analysis, presence of MDRO had no significant influence on healing time.
MDRO are pathogens frequently isolated from diabetic foot infection in our foot clinic. Nevertheless, their presence appears to have no significant impact on healing time if early aggressive treatment, as in the present study, is given, including empirical broad-spectrum antibiotic treatment, later adjusted according to microbiological findings.
确定获得多重耐药菌(MDRO)的危险因素及其对感染性糖尿病足溃疡预后的影响。
前瞻性纳入在我们糖尿病足病房因足部溃疡感染发作而住院的患者。感染的诊断基于使用国际糖尿病足工作组-美国传染病学会(IWGDF-ISDA)系统的临床发现,并获取伤口标本进行细菌培养。每位患者随访1年。进行单因素分析以比较有无MDRO的感染性溃疡;使用逻辑回归确定MDRO存在的解释变量。通过单因素和多因素生存分析评估与愈合时间相关的因素。
在188例研究患者中,45例(23.9%)分离出MDRO。深部和复发性溃疡、既往住院史、糖化血红蛋白(HbA1c)水平、肾病和视网膜病变与MDRO感染性溃疡显著相关。多因素分析显示,既往住院史(比值比[OR]=99.6,95%可信区间[CI]=[19.9 - 499.0])和增殖性视网膜病变(OR=7.4,95% CI=[1.6 - 33.7])显著增加MDRO感染风险。浅表溃疡与愈合时间显著缩短相关,而神经缺血性溃疡、增殖性视网膜病变和高HbA1c水平与愈合时间延长相关。多因素分析中,MDRO的存在对愈合时间无显著影响。
MDRO是我们足部诊所糖尿病足感染中经常分离出的病原体。然而,如果像本研究中那样给予早期积极治疗,包括经验性广谱抗生素治疗,随后根据微生物学结果进行调整,MDRO的存在似乎对愈合时间没有显著影响。